Relaxo Footwears Limited has informed the Exchange regarding a press release dated May 09, 2025, titled "Press Release on Audited Financial Results for the Quarter and FinancialYear ended on March 31, 2025".
RELAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.2 pts less than its Footwear peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Relaxo Footwears reported FY25 revenue of Rs. 2,790 crores, down 4% from Rs. 2,914 crores in FY24, citing weak demand in the mid-range footwear segment and distribution restructuring. FY25 EBITDA fell 6% to Rs. 382 crores with margin contracting 26 basis points to 13.7%. Profit after tax declined 15% to Rs. 170 crores (PAT margin 6.1% vs 6.9% earlier). In Q4 FY25 alone, revenue dropped 7% YoY to Rs. 695 crores, though it rose 4% sequentially. Management described FY25 as a year of consolidation, called it the 'bottom,' and expects an upward trajectory from H2 FY26 driven by the 'Relaxo Parivaar' app, 'Brand As Seller' model, and e-commerce push.
A weak print with declining revenue, margins, and profits is negative near-term, but management's confident tone about hitting the bottom and growth returning in H2 FY26 may limit downside. Investors should watch sequential recovery and margin trajectory in coming quarters to confirm the turnaround story.